Headlines:
Search for Healthcare Articles by Regulatory & Product Marketing

Biotechnology/Biologics


Previous   Page 1 of 27   Next >
Search returned 262 items.
sort by:   Title | Author | Publication | Date

Drug maker plans to disclose its payments to doctors

In an industry first, Eli Lilly and Co. says it will begin to tell how much money it paid to individual doctors for advice, speeches and other services
http://www.msnbc.msn.com/id/26858255/

FDA Issues Draft Guidance on Regulating Genetically Engineered Animals

Public comment invited on application of new animal drug provisions of the Federal Food Drug and Cosmetic Act
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01887.html

Beware of drug names that look, sound alike

Celebrex or Celexa? 1,500 common meds have caused mix-ups, study says
http://www.msnbc.msn.com/id/26497545/

FDA Announces Improved Policies Regarding Transparency, Public Disclosure for Advisory Committees

The improvements include stricter limits on financial conflicts of interest for committee members, ...
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01871.html

Drug Test a Success for Amgen

The biotechnology company reported a successful trial for an experimental osteoporosis drug that reduced the risk of bone fractures in post-menopausal women.
http://www.nytimes.com/2008/07/26/business/26amgen.html?ref=health

Health Plan From Obama Spurs Debate

It is one of the most audacious promises in a campaign that has been thick with them.
http://www.nytimes.com/2008/07/23/us/23health.html?ref=health

FDA Rule and Companion Guidance Make Early Stage Clinical Drug Development Safe and Efficient

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01863.html

While the U.S. Spends Heavily on Health Care, a Study Faults the Quality

But it has fallen to last place among those countries in preventing deaths through use of timely and effective medical care...
http://www.nytimes.com/2008/07/17/business/17health.html?ref=health

FDA Revises Process for Responding to Drug Applications

The U.S. Food and Drug Administration today announced that it is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01859.html

Possible lymphoma link to TNF-blockers sparks agency review

...including adalimumab (Humira, Abbott), etanercept (Enbrel, Amgen/Wyeth), infliximab (Remicade, Centocor), and certolizumab pegol (Cimzia, UCB Inc.)—for data on all cases of cancer reported in children and young adults...
http://drugtopics.modernmedicine.com/drugtopics/Allergies/Possible-lymphoma-lin
Previous   Page 1 of 27   Next >
Search returned 262 items.
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
Place your ad in this
Must-Read Pharma Mag
www.biotechmedia.com
Over 8,000,000 Mail and
Email addresses available
www.biotechmedia.com